Nanocarriers Based Novel Drug Delivery as Effective Drug Delivery: A Review

Author(s): Nitin R. Shirsath* , Ajaygiri K. Goswami .

Journal Name: Current Nanomaterials

Volume 4 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: A lot of people are facing some health-related problems in day to day life. The conventional drug delivery is not able to cure it alone, moreover, some drugs have poor solubility, low half-life and show lesser bioavailability. It is necessary to conduct research on carrier-based nanoparticulate drug delivery, this is an alternative approach to alter/eliminate the problem of conventional dosing for better effectiveness, patient compliance, and effective drug targeting.

Objective: To develop a carrier-based nanoparticulate drug delivery system for the elimination of problems associated with conventional dosage form.

Methods: In this review, different problems associated with conventional dosage form as well as potential advantages of the nanoparticulate delivery systems have been discussed. We also discussed their different route for administration such as oral, intranasal, ocular, transdermal, vaginal etc. for effective drug targeting. It has been found that different nanocarriers based drug delivery have been able to enhance the bioavailability, solubility, minimized adverse effect as well as effective in Gene delivery also. Ionic gelation, Solvent evaporation, emulsification, homogenization, lyophilisation, etc. are techniques used for their development.

Conclusion: The carrier-based drug delivery technique act as an effective drug delivery system for the treatment of various diseases/disorders as well as provides better efficiency, bioavailability and improve patient compliance.

Keywords: Nanocarriers, nanoparticles, bioavailability, application, sustained release, drug delivery.

[1]
Karunakar G, Patel NP, Kamal SS. Nano structured lipid carrier based drug delivery system. J Chem Pharm Res 2016; 8(2): 627-43.
[2]
Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 2018; 16(1): 71.
[3]
Svenson S. Carrier-Based Drug Delivery. ACS Symposium Series. Washington, DC. 2004.
[4]
Dahiya M, Dureja H. Recent developments in the formulation of nanoliposomal delivery systems. Curr Nanomater 2018; 3(2): 62-74.
[5]
Deshmukh RK, Naik JB. Diclofenac sodium-loaded Eudragit® microspheres: optimization using statistical experimental design. J Pharm Innov 2013; 8: 276-87.
[6]
Emeje MO, Eni-ike NE, Brown SA, Ofoefule SI. Preparation and in vitro release of hydrochlorothiazide from gellan beads produced by ionotropic gelation. Asian J Pharma 2009; 3(2): 153-5.
[7]
Hui Z, Kumar A, Wan P, Heng S. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci 2015; 10(4): 255-74.
[8]
Shafique M, Khan MA, Khan WS, Ahmad W, Khan S. Fabrication, characterization, and in vivo evaluation of famotidine loaded solid lipid nanoparticles for boosting oral bioavailability. J Nanomater 2017; 2017: 1-10.
[9]
Hetal T, Bindesh P, Sneha T. A review on techniques for oral bioavailability enhancement of drugs. Int J Pharm Sci Rev Res 2010; 4(3): 203-23.
[10]
Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. Int J Nanomedicine 2018; 13: 4727-45.
[11]
Vijaya Shanti B, Mrudula T, Pavan Kumar V. An imperative note on novel drug delivery systems. J Nanomed Nanotechnol 2011; 2: 125.
[12]
Lukianova-Hleb EY, Oginsky AO, Shenefelt DL, et al. Rainbow plasmonic nanobubbles: synergistic activation of gold nanoparticle clusters. J Nanomed Nanotechnol 2011; 2(104): 1-8.
[13]
Menaa B. The Importance of Nanotechnology in Biomedical Sciences. J Biotechnol Biomater 2011; 1: 105e.
[14]
Zheng J, Clogston JD, Patri AK, Dobrovolskaia MA, McNeil SE. Sterilization of silver nanoparticles using standard gamma irradiation procedure affects particle integrity and biocompatibility. J Nanomedic Nanotechnol 2011 2011; (Suppl 5:).001
[15]
Rosarin FS, Mirunalini S. Nobel metallic nanoparticles with novel biomedical properties. J Bioanal Biomed 2011; 3(4): 85-91.
[16]
Mehrotra A, Nagarwal RK, Pandit JK. Fabrication of lomustine loaded chitosan nanoparticles by spray drying and in vitro cytostatic activity on human lung cancer cell line L132. J Nanomed Nanotechnol 2010; 1: 103.
[17]
Nguyen KT. Targeted nanoparticles for cancer therapy: promises and challenges. J Nanomed Nanotechnol 2011; 2: 103e.
[18]
Yun Y, Conforti L, Muganda P, Sankar J. Nanomedicine-based synthetic biology. J Nanomedine Biotherapeutic Discov 2011; 1: 102e.
[19]
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001; 70(1-2): 1-20.
[20]
Agnihotri SA, Mallikarjuna NNAT, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004; 100(1): 5-28.
[21]
Vikas K, Arvind S, Ashish S, Gourav J, Vipasha D. Recent advances in Ndds (novel drug delivery system) for delivery of anti-hypertensive drugs. Int J Drug Dev Res 2011; 3(1): 252-9.
[22]
Caraglia M, De Rosa G, Abbruzzese A, Leonetti C. Nanotechnologies: new opportunities for old drugs. the case of aminobisphosphonates. J Nanomedine Biotherapeutic Discov 2011; 1(1): 10-1.
[23]
Douroumis D. Mesoporous silica nanoparticles as drug delivery system. J Nanomed Nanotechnol 2011; 2: 102e.
[24]
Patil A, Chirmade UN, Slipper I, Lamprou DA, Urquhart A. Encapsulation of water insoluble drugs in mesoporous silica nanoparticles using supercritical carbon dioxide. J Nanomed Nanotechnol 2011; 2: 111.
[25]
Thomas S, Waterman P, Chen S, et al. Development of secreted protein and acidic and rich in cysteine (sparc) targeted nanoparticles for the prognostic molecular imaging of metastatic prostate cancer. NIH Public Access 2012; 2(112): 2157-74392. -2-112
[26]
Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. Synthesis and characterization of biodegradable thiolated chitosan nanoparticles as targeted drug delivery system. J Nanomedic Nanotechnol S 2011; 4: 2.
[27]
Zhang Y, Zhi Z, Jiang T, Zhang J, Wang Z, Wang S. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release 2010; 145(3): 257-63.
[28]
Alagusundaram M, Chetty MSC, Umashankari K, Badarinath AV, Lavanya C, Ramkanth S. Microspheres-novel drug delivery system- a review. Int J Chemtech Res 2009; 1(3): 526-34.
[29]
Bhagvat RR, Vaidhya IS. Novel drug delivery systems : an overview. Int J Pharm Sci Res 2013; 4(3): 970-82.
[30]
Goyal A, Kumar S, Nagpal M, Singh I, Arora S. Potential of novel drug delivery systems for herbal drugs. Indian J Pharm Educ Res 2011; 45(3): 225-35.
[31]
Dibirdik I, Yiv S, Qazi S, Uckun FM. In vivo anti-cancer activity of a liposomal nanoparticle construct of multifunctional tyrosine kinase inhibitor 4-(4′-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline. J Nanomed Nanotechnol 2010; 1: 101.
[32]
Buckton G. Interfacial Phenomena in Drug Delivery and Targeting. 1st ed. CRC Press: Florida 2000.
[33]
Malhotra MJN. Niosomes as drug carriers. Indian Drugs-Bombay 1994; 31(3): 81-6.
[34]
Brewer JM, Alexander J. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology 1992; 75(4): 570-5.
[35]
Jayaraman SC, Ramachandran C, Weiner N. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J Pharm Sci 1996; 85(10): 1082-4.
[36]
Pragya RV. Resealed erythrocytes: a promising drug carrier. Int J Pharm Pharm Sci 2012; 4(3): 75-82.
[37]
Soni KS, Desale SS, Bronich TK. Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation. J Control Release 2016; 240: 109-26.
[38]
Pal SL, Jana U, Manna PK, Mohanta GP, Manavalan R. Nanoparticle: An overview of preparation and characterization. J Appl Pharm Sci 2011; 1(6): 228-34.
[39]
Patel NR, Patel DA, Bharadia PD, Pandya V, Modi D. Microsphere as a novel drug delivery. Int J Pharma Life Sci 2011; 2(8): 992-7.
[40]
Jain D, Panda AK, Majumdar DK. Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech 2005; 6(1): E100-7.
[41]
Gangadhar CB, Sunder SR, Kumar VM, Raju SM, Kiran SM. Formulation and evaluation of indomethacin microspheres using natural and synthetic polymers as controlled release dosage forms. Int J Drug Discov 2010; 2(1): 8-16.
[42]
Sampathi S. Preparation and evaluation of tramadol hydrochloride microspheres by coacervation phase separation technique using various solvents and non-solvents. J Glob Pharma Technol 2011; 3(4): 33-41.
[43]
Venkatesan P, Manavalan R, Valliappan K. Preparation and evaluation of sustained release loxoprofen loaded microspheres. J Basic Clin Pharm 2011; 2(3): 159-62.
[44]
Jyothi SS, Seethadevi A, Prabha KS, Muthuprasanna P, Pavitra P. Microencapsulation- a review. Int J Pharma Bio Sci 2012; 3(1): 509-31.
[45]
Singh M, Dua JS, Menra M, Soni M, Prasad DN. Microencapsulation and its various aspects: a review. Int J Adv Res 2016; 4(6): 2094-108.
[46]
Rewar S. bansal BK, singh CJ. Resealed erythocytes as carriers and its application in therapy. Int J Curr Res 2014; 1(10): 101-14.
[47]
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett 2013; 8(1): 102.
[48]
Jadhav SM, Morey P, Karpe MM, Kadam V. Novel vesicular system: An overview. J Appl Pharm Sci 2012; 2(1): 193-202.
[49]
Kumar P, Singh AK, Raj V, et al. Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations. Int J Nanomedicine 2018; 13: 975-90.
[50]
Behara AK, Barik BB. Preparation, characterization and in vitro evaluation of rifampicin loaded biodegradable microsphere. Anal Chem Indian J 2013; 13(7): 263-9.
[51]
Harsha NS, Harsha NS. In vitro and in vivo evaluation of nanoparticles prepared by nano spray drying for stomach mucoadhesive. Dry Technol 2015; 33(10): 1199-209.
[52]
Ramesh CN, Bhuvaneswara Rao C, Balakrishnan M, Chandra Sekhar KB. Preparation and characterization o piolitazone HCL solid inclusion and- an solubility enhancement technique. Intl J Biopharma 2014; 5(3): 180-3.
[53]
Mokale V, Jitendra N, Yogesh S. Chitosan reinforced alginate controlled release beads of losartan potassium : design, formulation and in vitro evaluation. J Pharm Investig 2014; 44: 243-52.
[54]
Cao SL, Ren XW, Zhang QZ, et al. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm 2009; 365(1-2): 109-15.
[55]
Khairnar G, Mokale V, Naik J. Formulation and development of nateglinide loaded sustained release ethyl cellulose microspheres by O / W solvent emulsification technique. J Pharm Investig 2014; 44(80): 411-22.
[56]
Bagchi M, Amin L, Al-Mamun A, Sutradhar KB, Huda NH. Development of natural gum based glipizide mucoadhesive microsphere. J Appl Pharm Sci 2014; 4(1): 66-9.
[57]
Akinluwade KJ, Oyatogun GM, Alebiowu G. Morphology analysis of chitosan- acacia gum nanoparticles loaded and unloaded with cisplatin. Eur J Pharm Med Res 2018; 5(6): 162-6.
[58]
Chittasupho C, Jaturanpinyo M, Mangmool S. Pectin nanoparticle enhances cytotoxicity of methotrexate against HepG2 cells. Drug Deliv 2013; 20(1): 1-9.
[59]
Mohd M, Sathish A, Prakash G, Sarika M, Thaiseen B, Ramakrishna R. Formulation and evaluation of mucoadhesive microspheres of pioglitazone hydrochloride using a natural polymer. Int J Pharm Sci Res 2015; 6(4): 723-37.
[60]
Janakidevi S, Ramanamurthy KV. Design of novel colon targeted microsponges loaded with diclofenac sodiun using tree different polymers. Int Res J Pharm 2018; 9(4): 9-10.
[61]
Parveen A, Syed IA. Formulation and evaluation of mucoadhesive microspheres of lamivudine. Int J Pharm Sci Drug Res 2014; 6(2): 102-8.
[62]
Jaya RK, Naga HP, Umadevi SK. Formulation and evaluation of hpmc / sodium alginate / carbopol based pioglitzone beads. Res J Pharm Biol Chem Sci 2012; 3(4): 815-23.
[63]
Rajan K. Verma, Sanjay Garg. Current status of drug delivery technologies and future directions. Pharm Technol 2001; 25(2): 1-14.
[64]
Zhu C, Cui L. The role of Ahr in anticancer drug resistance in breast cancer. J Bioanal Biomed 2015; 7(11): 87-90.
[65]
Wagh P, Naik J. Formulation and characterization of ketoprofen embedded polycaprolactone microspheres using solvent evaporation method. ADMET DMPK 2015; 3(2): 141-53.
[66]
Packhaeuser CB, Schnieders J, Oster CGKT, Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 2004; 58(2): 445-55.
[67]
Christrup LL, Lundorff L, Werner M. Novel formulations and routes of administration for opioids in the treatment of breakthrough pain. Therapy 2009; 6(5): 695-706.
[68]
Abbas Z, Marihal S. Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: formulation optimization using factorial design, characterization, and in vitro evaluation. J Pharm Bioallied Sci 2014; 6(4): 267-77.
[69]
Arunachalam A, Karthikeyan M, Vinay Kumar D, et al. Transdermal drug delivery system: a review. Current Pharma Research 2010; 1(1): 70-81.
[70]
Yoshiba S, Okabe H, Ishizuka H. Prodrug, laninamivir octanoate, a long-Acting neuraminidase inhibitor, using an easy-to-use inhaler in healthy volunteers. J Bioequivalence Bioavailab 2011; 3(1): 1-4.
[71]
Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14(2): 101-14.
[72]
Manivannan R, Parthiban KG. recent advance in novel drug delivery system. Int J Res Ayurveda Pharm 2010; 1(2): 316-26.
[73]
Bajaj A, Desai M. Challenges and strategies in novel drug delivery technologies. Pharm Times 2006; 38: 12-6.
[74]
Miranda MS, Rodrigues MT, Domingues RMA, et al. Development of inhalable superparamagnetic iron oxide nanoparticles (spions) in microparticulate system for antituberculosis drug delivery. Adv Healthcare Mater 2018; 7(15)1800124
[75]
Zhao Y, Haney MJ, Mahajan V, et al. Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of parkinson’s disease. J Nanomed Nanotechnol 2011; S4: 1-21.
[76]
Rao YS, Chandana R, Varalakshmi TS, Vijaya L, Chowdary KPR. Formulation and in vitro evaluation of colon targeted matrix tablets of mebeverine hydrochloride using natural polymers. J Pharm Res 2014; 8(11): 1682-9.
[77]
Shen J, Wang Y, Ping Q, Xiao Y, Huang X. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 2009; 137(3): 217-23.
[78]
Rajendran N, Natrajan R. Kumar Rs, Selvaraj S. Acyclovir-loaded chitosan nanoparticles for ocular delivery. Asian J Pharm 2010; 4(4): 220-6.
[79]
Mahapatra LR, Sahoo G. K. Panda M, ch. Parija S. Pharmacokinetic profile of nimesulide in bovine calves. J Bioequiv 2009; 1(4): 121-6.
[80]
Matricardi P, Pontoriero M, Coviello T, Casadei MA, Alhaique F. In situ cross-linkable novel alginate-dextran methacrylate IPN hydrogels for biomedical applications: mechanical characterization and drug delivery properties. Biomacromolecules 2008; 9(7): 2014-20.
[81]
Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN, Nagao T. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomedicine 2012; 7: 1851-63.
[82]
Gaur PK, Mishra S, Bajpai M, Mishra A. Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies. BioMed Res Int 2014; 20142014363404
[83]
Arayne MS, Sultana N. Porous nanoparticles in drug delivery systems. Pak J Pharm Sci 2006; 19(2): 158-69.
[84]
Vinita P, Shiv MK, Mahavir Y, Archana T. Liposome : a powerful approach festinates drug delivery system. Int J Drug Deliv Technol 2013; 3(1): 7-10.
[85]
Kumar R, Chandra A, Gautam PK, Shrivastave A. Resealed erythrocytes as a novel carrier for drug delivery: a review. Int J Pharm Sci Res 2013; 8: 2880-92.
[86]
Sharma D, Maheshwari D, Philip G, et al. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. BioMed Res Int 2014; 2014156010
[87]
Sonvico F, Clementino A, Buttini F, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics 2018; 10(1): 1-34.
[88]
Rençber S, Karavana SY, Şenyiğit ZA, Eraç B, Limoncu MH, Baloğlu E. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation. Pharm Dev Technol 2017; 22(4): 551-61.
[89]
Leyva-Gómez G, Piñón-Segundo E, Mendoza-Muñoz N, Zambrano-Zaragoza ML, Mendoza-Elvira S, Quintanar-Guerrero D. Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art. Int J Mol Sci 2018; 19(6): 1-19.
[90]
Bonferoni MC, Giunchedi P, Scalia S, Rossi S, Sandri G, Caramella C. Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms. AAPS PharmSciTech 2006; 7(4): 104.
[91]
Dhiman S, Singh TG, Rehni AK. Transdermal patches: a recent approch to new drug delivery system. Int J Pharm Pharm Sci 2011; 3(5): 26-34.
[92]
Thulasiramaraju TV, Kumar BT, Nikilesh Babu M. Pulmonary drug delivery system: an overview. Asian J Res Pharm Sci Biotechnol 2013; 1(1): 16-34.
[93]
Ren Y, Jiang L, Yang S, et al. Design and preparation of a novel colon-targeted tablet of hydrocortisone. Braz J Pharm Sci 2016; 52(2): 239-50.
[94]
Nayak S, Jadhav M, Bhaskar V. Recent advances in ocular drug delivery systems. Res J Pharm Technol 2016; 9(7): 995-1006.
[95]
Waghulde MR, Naik JB. Poly-e-caprolactone-loaded miglitol microspheres for the treatment of type-2 diabetes mellitus using the response surface methodology. J Taibah Univ Med Sci 2016; 11(4): 364-73.
[96]
Mazumder B, Bera K, Sarwa K. Metformin HCl loaded mucoadhesive agar microspheres for sustained release. Asian J Pharm 2013; 7(2): 75.
[97]
Hanif H, Nazir S, Mazhar K, Waseem M, Bano S, Rashid U. Targeted delivery of mesoporous silica nanoparticles loaded monastrol into cancer cells: an in vitro study. Appl Nanosci 2017; 7(8): 549-55.
[98]
Reis CP, Ferreira JP, Candeias S. Ibuprofen nanoparticles for oral delivery: proof of concept. J Nanomedine Biotherapeutic Discov 2014; 4(1): 1-5.
[99]
Gavini V, Ragini B, Kaumudi K, Hills V. Mucoadhesive microspheres-a novel approach of drug targeting. World J Pharm Pharm Sci 2014; 3(10): 310-35.
[100]
Ravikumar V, Anbarasan K. Nanoparticles and their applications- a mini review. Eng Biosci 2015; 3(5): 11-29.
[101]
Yohan D, Chithrani BD. Applications of nanoparticles in nanomedicine. J Biomed Nanotechnol 2014; 10(9): 2371-92.
[102]
Vaghela H, Shah R, Pathan A. Palladium nanoparticles mediated through bauhinia variegata: potent in vitro anticancer activity against mcf-7 cell lines and antimicrobial assay. Curr Nanomater 2018; 3(3): 168-77.
[103]
Dupré L, Kremer L, Wolowczuk I, Riveau G, Capron A, Locht C. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection. Vaccine 2001; 19(11-12): 1373-80.
[104]
Bhatia S. Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications.In: Bhatia S.. Natural Polymer Drug Delivery Systems. 1st ed. Switzerland: Springer International Publishing 2016; pp. 33-93.
[105]
Chiowchanwisawakit P, Nilganuwong S, Srinonprasert V, et al. Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy. Int J Rheum Dis 2013; 16(1): 47-55.
[106]
Nayak AK, Malakar J, Sen KK. Gastroretentive drug delivery technologies: Current approaches and future potential. J Pharm Educ Res 2010; 1(2): 1-12.
[107]
Roiha IS, Otterlei E, Samuelsen OB. Bioencapsulation of Florfenicol in Brine Shrimp , Artemia Franciscana , Nauplii. J Bioanal Biomed 2010; 2(3): 060-4.
[108]
Verma U, Naik JB, Mokale VJ. Preparation and characterisation of the inclusion complex of famotidine with (2-hydroxy propyl)–β-cyclodextrin & pvp k-30: effects on solubility and bitter taste mask. Int Conf Adv Chem Eng Technol 2014; p. 63.
[109]
Kumar S, Dilbaghi N, Saharan R. Nanotechnology as emerging tool for enhancing solubility of poorly water-soluble drugs. BioNanoSci 2012; 2(4): 227-50.
[110]
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46(1-3): 3-26.
[111]
Urbanetz NA. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci 2006; 28(1-2): 67-76.
[112]
Verma U, Naik J, Mokale VJ. Preparation of freeze-dried solid dispersion powder using mannitol to enhance solubility of lovastatin and development of sustained release tablet dosage. American J Pharma Sci Nanotechnol 2014; 1(1): 11-26.
[113]
Marcato PD, Durán N. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol 2008; 8(5): 2216-29.
[114]
Dadhania P, Vuddanda PR, Jain A, Velaga S, Singh S. Intranasal delivery of asenapine loaded nanostructured lipid carriers: Formulation, characterization, pharmacokinetic and behavioural assessment. RSC Advances 2016; 6(3): 2032-45.
[115]
Abhinav M, Neha J, Anne G, Bharti V. Role of novel drug delivery systems in bioavailability enhancement: at A glance. Int J Drug Deliv Technol 2016; 6(1): 7-26.
[116]
Harikhrushna D. Role of nanotechnology in pharmaceutical product development. J Pharm Sci 2007; 96(10): 2547-65.
[117]
Havanoor SM, Kopparam M, Bhagawati ST, Veerapur PV. Isradipine loaded silica lipid nanoparticles for better treatment of hypertension- preparation, charecterization and in vitro evaluation. Int J Biopharma 2014; 5(3): 218-24.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 4
ISSUE: 2
Year: 2019
Page: [71 - 83]
Pages: 13
DOI: 10.2174/2405461504666190527101436

Article Metrics

PDF: 6
HTML: 1